PARTIAL LIPODYSTROPHY
Clinical trials for PARTIAL LIPODYSTROPHY explained in plain language.
Never miss a new study
Get alerted when new PARTIAL LIPODYSTROPHY trials appear
Sign up with your email to follow new studies for PARTIAL LIPODYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could blocking growth hormone ease severe insulin resistance?
Disease control Recruiting nowThis study tests a drug called pegvisomant in 25 adults with severe insulin resistance caused by lipodystrophy or insulin receptor gene changes. Participants give themselves daily shots for one month and have two hospital stays for tests. The goal is to see if blocking growth hor…
Matched conditions: PARTIAL LIPODYSTROPHY
Phase: PHASE2 • Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Hope for rare fat disorder: expanded access to metreleptin offered
Disease control AVAILABLEThis expanded access program provides metreleptin (MyaLept) to patients with familial partial lipodystrophy who also have diabetes or very high triglycerides. Metreleptin is already approved for generalized lipodystrophy, but this program aims to help those with the partial form.…
Matched conditions: PARTIAL LIPODYSTROPHY
Sponsor: University of Michigan • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New registry tracks Real-World safety of rare disease drug metreleptin
Disease control Recruiting nowThis registry monitors the safety and effectiveness of metreleptin in up to 100 people with generalized or partial lipodystrophy who are already taking the drug in routine care. Researchers will track serious events like pancreatitis, liver problems, infections, and cancers. The …
Matched conditions: PARTIAL LIPODYSTROPHY
Sponsor: Amryt Pharma • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC